EZH2-TTP-mTORC1 Axis Drives Phenotypic Plasticity and Therapeutic Vulnerability in Lethal Prostate Cancer
Preprint
- 21 August 2025
- preprint
- Published by Springer Nature in Research Square
Abstract
Phenotypic plasticity is a recognized mechanism of therapeutic resistance in prostate cancer (PCa), however current knowledge of driver mechanisms and therapeutic interventions are limited. Using genetically engineered mouse models (GEMMs) devoid of Pten and Rb1, we previously demonstrated the chromatin reprogramming factor enhancer of zeste homolog 2 (EZH2) as an important regulator of alternative transcription programs promoting phenotypic plasticity. Here, using a multi-omics approach we demonstrate that EZH2 regulates multilineage cell states dependent on the RNA binding protein Tristetraprolin (TTP) that mediates RNA stability and activation of translation. Combined chemical inhibition of EZH2 and PI3K/mTORC1 resulted in superior anti-tumor activity in murine and human phenotypic plastic models and was most significant when this combination was used with castration or enzalutamide. Together, these data indicate phenotypic plasticity dependence on coordination between EZH2, TTP and mTORC1 signaling that represent novel therapeutic dependencies for this lethal PCa phenotype.Keywords
All Related Versions
This publication has 66 references indexed in Scilit:
- Assessments of prostate cancer cell functions highlight differences between a pan‐PI3K/mTOR inhibitor, gedatolisib, and single‐node inhibitors of the PI3K/AKT/mTOR pathwayMolecular Oncology, 2024
- Dual targeting of the androgen receptor and PI3K/AKT/mTOR pathways in prostate cancer models improves antitumor efficacy and promotes cell apoptosisMolecular Oncology, 2024
- Single‐cell analysis of mouse and human prostate reveals novel fibroblasts with specialized distribution and microenvironment interactionsThe Journal of Pathology, 2021
- Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF SignalingCancer Cell, 2017
- N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate CancerCancer Cell, 2016
- Nfib Promotes Metastasis through a Widespread Increase in Chromatin AccessibilityCell, 2016
- Acquired Tissue-Specific Promoter Bivalency Is a Basis for PRC2 Necessity in Adult CellsCell, 2016
- Identification of Multipotent Luminal Progenitor Cells in Human Prostate Organoid CulturesCell, 2014
- Adult Murine Prostate Basal and Luminal Cells Are Self-Sustained Lineages that Can Both Serve as Targets for Prostate Cancer InitiationCancer Cell, 2012
- A Bivalent Chromatin Structure Marks Key Developmental Genes in Embryonic Stem CellsCell, 2006